Compare · RLX vs UPXI
RLX vs UPXI
Side-by-side comparison of RLX Technology Inc. (RLX) and Upexi Inc. (UPXI): market cap, price performance, sector, and recent activity on the wire.
Summary
- Both RLX and UPXI operate in Medicinal Chemicals and Botanical Products (Health Care), so they compete in similar markets.
- RLX is the larger of the two at $2.77B, about 34.6x UPXI ($80.1M).
- RLX has hit the wire 4 times in the past 4 weeks while UPXI has been quiet.
- Both have 2 recent analyst ratings on file.
- Company
- RLX Technology Inc.
- Upexi Inc.
- Price
- -
- -
- Market cap
- $2.77B
- $80.1M
- 1M return
- -12.04%
- -
- 1Y return
- -25.10%
- -
- Industry
- Medicinal Chemicals and Botanical Products
- Medicinal Chemicals and Botanical Products
- Exchange
- NYSE
- NASDAQ
- IPO
- 2021
- 2021
- News (4w)
- 4
- 0
- Recent ratings
- 2
- 2
RLX
RLX Technology Inc.
RLX Technology Inc., together with its subsidiaries, researchers, develops, manufactures, distributes, and sells e-vapor products in the People's Republic of China. It serves RELX branded partner stores and other retail outlets through distributors. RLX Technology Inc. was founded in 2018 and is based in Beijing, China.
Latest RLX
- SEC Form 6-K filed by RLX Technology Inc.
- RLX Technology Announces Unaudited Second Quarter 2026 Financial Results
- RLX Technology to Report Second Quarter 2026 Financial Results on August 14, 2026
- SEC Form 4 filed by Chief Financial Officer Lu Chao
- SEC Form 6-K filed by RLX Technology Inc.
- RLX Technology Announces Unaudited First Quarter 2026 Financial Results
- RLX Technology to Report First Quarter 2026 Financial Results on May 20, 2026
- RLX Technology Files 2025 Annual Report on Form 20-F
- SEC Form 20-F filed by RLX Technology Inc.
- SEC Form 3 filed by new insider Wang Ying Kate
Latest UPXI
- Upexi Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Financial Statements and Exhibits
- Director Salkind Gene was granted 100,000 shares, increasing direct ownership by 46% to 318,750 units (SEC Form 4)
- Director Dugan Lawrence was granted 100,000 shares, increasing direct ownership by 86% to 216,389 units (SEC Form 4)
- Chief Strategy Officer Rudick Brian Benjamin was granted 400,000 shares, increasing direct ownership by 48% to 1,238,597 units (SEC Form 4)
- Chief Executive Officer Marshall Allan was granted 2,000,000 shares, increasing direct ownership by 49% to 6,046,261 units (SEC Form 4)
- Chief Financial Officer Norstrud Andrew James was granted 400,000 shares, increasing direct ownership by 62% to 1,049,138 units (SEC Form 4)
- SEC Form EFFECT filed by Upexi Inc.
- SEC Form 424B3 filed by Upexi Inc.
- SEC Form S-3 filed by Upexi Inc.
- Upexi Inc. filed SEC Form 8-K: Other Events, Financial Statements and Exhibits